The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Venbio Global Strategic Fund Ii L.p. since 2017.
The trader's CIK number is 1634632.
At the time of the last reporting, Venbio Global Strategic Fund Ii L.p. was the 10% Owner of Menlo Therapeutics Inc.. (stock ticker symbol MNLO).
Also see all insider trading activities at Menlo Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | APLS | 127,515 | $1,785,210 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | MNLO | 265,000 | $4,505,000 | 0 | $0 | 0 | $0 |
1. Apellis Pharmaceuticals, Inc. (APLS)
2. Menlo Therapeutics Inc. (MNLO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-11-13 | APLS | Buy | 127,515 | 14.00 | 1,785,210 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-01-25 | MNLO | Buy | 265,000 | 17.00 | 4,505,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Venbio Global Strategic Fund Ii L.p. (10% Owner of Menlo Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.